KR20170090362A - Composition having sleep-improving effect comprising an extract of herbal combination, and uses thereof - Google Patents

Abstract

The present invention relates to a composition for enhancing or improving sleep, and to uses thereof, and more specifically, to a composition for enhancing or improving sleep comprising combined plant extracts, and to a composition for preventing, improving, or treating sleep disorders, or insomnia. Since the combined plant extracts of the present invention has little side effects and is excellent in the effect of enhancing, increasing and improving sleep, thereby being usefully used as a pharmaceutical composition and a health functional food for preventing, ameliorating and treating sleep disorders or insomnia. In addition, according to the present invention, a new therapeutic agent and a therapeutic method surpassing existing natural anti-insomnia agents can be provided.

Description

[0001] The present invention relates to a composition for enhancing or improving sleep, comprising a combination herbal extract and a composition for sleep enhancement or improvement,

More particularly, the present invention relates to a composition for enhancing or improving sleeping ability containing a herbal extract, a composition for preventing, ameliorating or treating sleep disorders or insomnia.

Many people in the modern world suffer from sleep disturbance because of stress, anxiety, and agitation. According to the statistics, about 15% of adults are known to need medication due to insomnia due to anxiety symptoms. Insomnia is caused by stress, tension, and fear. Therapeutic drugs include benzodiazepines and serotonin Drugs, etc., are used. However, these drugs have a serious side effect of being formed with tolerance and dependency when they are used for a long period of time.

Accordingly, the need for natural supplements is increasing as a means of replacing long-term sleepers and restaurateurs, and there is a growing demand for functional foods for sleep enhancement, 10-1333982), but it is still small.

On the other hand, Yam (山藥) is a rhizome of yam (Dioscorea japonica Thunb) or village (Dioscorea batatas Thunb) belonging to magwa (Dioscoreaeaceae), the taste is sweet nature is warm. Studies on anticancer, antioxidant, immunity increasing, and defense against stress have been reported.

Hwaseongcho (魚 腥草) is the top part of the flowering period of the Hwangtimnyeong ( Houttuynia cordata Thunberg), and the taste is spicy and the quality is a bit cold. Anti-inflammatory, anti-cancer, and immunity-enhancing effects of Hwasungcho have been reported.

The dragon eye meat (dragon eye meat) refers to the seed coat of the dragon eye ( Dimocarpus longan Lour .: dragon eye), and the taste is sweet and the quality is warm. Ryeonggak has been reported to improve memory and stress.

The present inventors, as a result of intensive studies in order to promote sleep or develop an excellent natural substance improving effect without side effects, Yam (Dioscoreae batatas Decaisne), by ensuring that the Houttuynia cordata (Houttuynia cordata THUNB), combined herbal extracts having excellent promotion or improvement of sleep yonganyuk (Euphoria longana STEUD) effect and completed the present invention.

Accordingly, an object of the present invention is to provide a composition for enhancing or improving sleep quality, which comprises an extract of a complex herbal medicine of Lycopersicon esculentum, Lycopersicon esculentum, and Pigmentosa as an active ingredient.

It is still another object of the present invention to provide a composition for preventing, ameliorating or treating sleep disorders or insomnia, which comprises an extract of a complex herbal medicine of Acanthopanax senticosus, Acanthopanax senticosus and Pigmentosa as an active ingredient.

However, the technical problem to be solved by the present invention is not limited to the above-mentioned problems, and other matters not mentioned can be clearly understood by those skilled in the art from the following description.

In order to achieve the above object, the present invention provides a composition for enhancing or improving sleep quality, which comprises an extract of a complex herbal medicine consisting of Acanthopanax senticosus, Acanthopanax senticosus and Pigmentosae as active ingredients.

In addition, the present invention provides a pharmaceutical composition for preventing or treating sleep disorder or insomnia, which comprises, as an active ingredient, a complex herbal medicine extract of Acanthopanax senticosus, Acanthopanax senticosus and Pigmentosa.

The present invention also provides a health functional food composition for improving sleeping disorder or insomnia, which comprises, as an active ingredient, a complex herbal medicine extract of lily of the valley, lily of the valley and yin yang.

In one embodiment of the present invention, the extract can be extracted using water, a C ₁ to C ₄ lower alcohol, or a mixed solvent thereof.

In another embodiment of the present invention, the lower alcohol may be ethanol.

In another embodiment of the present invention, the extract may be mixed and extracted at a weight ratio of 1: 0.1 to 10: 0.1 to 10 in the range of 1: 0.1 to 10: 1.

In another embodiment of the present invention, the weight ratio may be 1: 1: 1.

The present invention also provides a method for preventing or treating sleep disorders or insomnia comprising the step of administering the composition to a subject.

The present invention provides a composition for preventing or treating sleep disorders or insomnia.

The complex herbal medicine extract of the present invention has little side effects and is excellent in the effect of enhancing, increasing and improving sleeping. Therefore, it can be effectively used as a pharmaceutical composition and health functional food for preventing, ameliorating and treating sleep disorder or insomnia. In addition, according to the present invention, a new therapeutic agent and a therapeutic method that exceed the existing natural antihypertensive agents can be provided.

FIG. 1 and FIG. 2 show the results of measurement of brain waves after administration of the herbal medicine extract to confirm the effect of improving the sleepiness of the herbal medicine extracts.
FIG. 3 shows the result of confirming the change of the movement activity of Drosophila by the herbal extract of the complex herb.

The present invention provides a composition for enhancing or improving sleepiness, which comprises an extract of a complex herbal medicine of lily of the sea, herringbone and eyelid as an active ingredient.

The sleep enhancement or improvement may be an effect of reducing the sleep latency and increasing the sleep duration, but is not limited thereto.

In the composition of the present invention, the herbal extract of the present invention may be obtained by a conventional extraction method, and a commercially available herbal extract may be used. Typical extraction methods include, but are not limited to, hot water extraction, cold extraction, reflux extraction, ultrasonic extraction, and the like.

More specifically, the herbal extract of the present invention is prepared by washing the herbal materials Dioscoreae batatas Decaisne, Houttuynia cordata THUNB, and Euphoria longana STEUD with water, 1 to 20 times, preferably about 2 to 10 times the volume of water, a C1 to C4 lower alcohol or a mixture thereof, preferably 30% ethanol at a temperature of 0 to 120 DEG C for about 1 hour to 1 day The extract may be filtered after cooling, and the filtrate may be lyophilized to obtain the herbal extract of the present invention.

Preferably, the extract is mixed and extracted at a weight ratio of 1: 0.1 to 10: 0.1 to 10, and most preferably mixed at a weight ratio of 1: 1: 1.

In one embodiment of the present invention, it was found that the combination of herbal extracts of Sanskrit, Hwasungcho, and Yongcheng resulted in improvement of sleeping and improving effects of both herb extracts and TUKEY HSD and LSD in wake and rem . In the Drosophila dementia model, the night mobility was significantly lowered in the herbal extract-treated group than in the control group, and the low mobility was significantly increased (see Example 2).

Therefore, the compound herbal medicine extract of the present invention can be used as medicines and health functional foods useful for preventing, ameliorating, inhibiting or treating sleep disorder or insomnia by improving, increasing or improving sleeping surface.

Accordingly, as another aspect of the present invention, the present invention provides a pharmaceutical composition for preventing or treating sleep disorder or insomnia, which comprises, as an active ingredient, a complex herbal medicine extract of lily of the valley,

The pharmaceutical composition of the present invention may contain at least one known active ingredient having a therapeutic effect on sleep disorder or insomnia together with the herbal extract of the present invention.

The compositions of the present invention may further comprise suitable carriers, excipients and diluents conventionally used in the manufacture of pharmaceutical compositions. In addition, it can be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, oral preparations such as syrups and aerosols, external preparations, suppositories and sterilized injection solutions according to a conventional method.

Examples of carriers, excipients and diluents that can be included in the composition include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methylcellulose , Microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. When the composition is formulated, it is prepared using a diluent such as a filler, an extender, a binder, a wetting agent, a disintegrant, a surfactant, or an excipient usually used.

The pharmaceutical composition of the present invention may be administered orally or parenterally (for example, intravenously, subcutaneously, intraperitoneally or topically) depending on the intended method, and the dose may vary depending on the condition and the weight of the patient, The mode of administration, the route of administration, and the time, but may be appropriately selected by those skilled in the art.

The pharmaceutical composition of the present invention is administered in a pharmaceutically effective amount. In the present invention, "pharmaceutically effective amount" means an amount sufficient to treat a disease at a reasonable benefit / risk ratio applicable to medical treatment, and an effective dosage level is determined depending on the type of disease, severity, , Sensitivity to the drug, time of administration, route of administration and rate of release, duration of treatment, factors including co-administered drugs, and other factors well known in the medical arts. The pharmaceutical composition of the present invention can be administered as an individual therapeutic agent or in combination with other therapeutic agents, and can be administered sequentially or simultaneously with conventional therapeutic agents, and can be administered singly or in multiple doses. It is important to take into account all of the above factors and to administer the amount in which the maximum effect can be obtained in a minimal amount without side effects, which can be easily determined by those skilled in the art.

Specifically, the effective amount of the pharmaceutical composition of the present invention may vary depending on the age, sex, condition, body weight, the degree of absorption of the active ingredient in the body, the rate of inactivation and excretion, the type of disease, May be administered in a daily dose of 0.0001 to 150 mg, preferably 0.001 to 100 mg, per 1 kg of body weight or one to three divided doses per day. However, the dosage may be varied depending on the route of administration, the severity of obesity, sex, weight, age, etc. Therefore, the dosage is not limited to the scope of the present invention by any means.

According to still another aspect of the present invention, there is provided a health functional food composition for improving sleeping disorder or insomnia, which comprises, as an active ingredient, a complex herbal extract of lily of the valley,

The term "improvement" as used in the present invention means all actions that at least reduce the degree of symptom associated with the condition being treated.

The composition of the present invention may be added to health functional foods for the purpose of preventing or ameliorating sleep disorders or insomnia. When the complex herbal medicine extract of the present invention is used as a food additive, the herbal medicine extract may be added as it is or may be used together with other food or food ingredients, and may be appropriately used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to the intended use (prevention, health or therapeutic treatment). In general, the herbal extract of the present invention is added in an amount of not more than 15% by weight, preferably not more than 10% by weight based on the raw material. However, in the case of long-term intake for the purpose of health and hygiene or for the purpose of health control, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount exceeding the above range.

There is no particular limitation on the kind of the food. Examples of the food to which the above substances can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, other noodles, gums, ice cream, various soups, drinks, tea, Alcoholic beverages, and vitamin complexes, all of which include health functional foods in a conventional sense.

The health beverage composition of the present invention may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages. The above-mentioned natural carbohydrates are monosaccharides such as glucose and fructose, polysaccharides such as disaccharides such as maltose and sucrose, dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The ratio of the natural carbohydrate is generally about 0.01 to 0.20 g, preferably about 0.04 to 0.10 g per 100 ml of the composition of the present invention.

In addition to the above, the composition of the present invention may further contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acids and salts thereof, alginic acid and its salts, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, A carbonating agent used in a carbonated beverage, and the like. In addition, the composition of the present invention may contain flesh for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components may be used independently or in combination. Although the ratio of such additives is not critical, it is generally selected in the range of 0.01 to 0.20 parts by weight per 100 parts by weight of the composition of the present invention.

Further, as another embodiment of the present invention, the present invention provides a method for preventing or treating sleep disorder or insomnia comprising the step of administering to a subject a complex herbal extract of lily of the valley, herringbone and eyedropper. The subject is a mammal including a human or non-human, and non-human mammals include, but are not limited to, mice, rats, dogs, cats, horses, cows, sheep, goats, pigs, rabbits and the like.

Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are provided only for the purpose of easier understanding of the present invention, and the present invention is not limited by the following examples.

[Example]

Example 1. Experimental Preparation and Experimental Method

1-1. Preparation of complex herbal medicine extract

The herbal medicine used in this experiment was purchased from Dongyang Hub Co., Ltd. First, the shiitake mushroom, shiitake mushroom, and yongcunmyk were shredded and shredded, mixed with 33 g of acid moss, 33 g of mushroom and 33 g of yongsanmyeol, and the mixture was added to 1 L of 30% ethanol, followed by lyophilization. 100 mg of the lyophilized sample was dissolved in 1 ml of 30% ethanol, and the impurities were removed with a 0.2-μm filter and used as a sample.

1000 mg, and 3000 mg of the complex medicines (mixed with liquorice, horseradish, and yogurts at a weight ratio of 1: 1: 1), which are taken by an adult having a body weight of 60 kg, were prepared.

HED (mg / kg) = Animal dose (mg / kg) X Animal Km / Human Km

1-2. Experimental animal

Sprague-Dawley male rats (Samtaco, Korea) were used at a dose of 250 g. Pre-operative animals were placed in a breeding box in the breeding room to allow the animals to freely eat water and food. The environment of the breeding room was controlled by 12 hours (lighting at 08: 00-20: 00), the temperature was 20 ~ 25 ℃ and the humidity was 45 ~ 65%.

1-3. Surgery

The operation was divided into 3 groups (normal, A200; 200 mg / kg, A400; 400 mg / kg) Pentobarbital (40 mg / kg) was anesthetized by intraperitoneal injection of the animals for surgery. The anesthetized rats were placed on a stereotaxic instrument (Stoelting CO, USA) and the bregma and lambda points were leveled. After curbing the bleeding under the scalp, the hair was cut, the scalp was incised, and the incised skin was opened to expose the skull surface to remove the periosteum and expose the bones. To prevent inflammation, tissues such as the periosteum of the skull surface and blood were cleaned and wiped with 70% alcohol for disinfection. Drill holes were made according to the dissection of Paxinos and Watson, and the electrode was inserted into contact with the dura. Two electrodes were inserted into the neck muscles for EMG recording. Electroencephalogram recording electrodes and connected electrodes of EMG recording electrodes were placed on the upper cerebellum of the cerebellum and fixed on the upper part of the skull by applying dental cement. The animals were placed in a breeding box in the breeding room and were restored for 1 week. During the recovery phase, 12-hour light cycle was applied and water and food were freely consumed.

1-4. EEG ( Electroencephalography ; EEG)

After recovery, the mice were adapted to the experimental conditions. Each drug was administered orally and 10 minutes later EEG recording (from 8:00 pm for 12 hours) was performed. Sleep, rapid eye movement, and non-REM sleep were measured using SleepSign Ver. 3 software (Kissei Comtec, Nagano, Japan).

Sleep latency is defined as the elapsed time between sample administration and the first consecutive NREM sleep episode lasting at least 2 minutes, continuing for more than six 4-s periods, and not recorded as NREM sleep. The EEG power spectra were calculated at 0.5 Hz intervals and integrated to calculate the mean. This was divided into three frequency regions: delta wave activity (0.65-4 Hz), theta wave activity (6-10 Hz) and alpha wave activity (12-14 Hz). The EEG power density of NREM sleep was normalized to one group by calculating the percentage of each interval from the total EEG power (0-20 Hz) of the individual rats. On the other hand, the sleep-wake state is generally specified as follows:

Arousal: low-amplitude EEG and high-voltage EMG activity;

NREM sleep: high-amplitude slow or spindle EEG and low-voltage EMG activity;

REM sleep: low-voltage EEG and EMG activity.

Example  2. Identification of improvement of sleep and improvement effect of herbal medicine extract

2-1. Identification of the effect of sleeping on animal models by herbal extracts

The animals subjected to the surgery by the method described in the above Example 1-3 were measured for brain waves by the method described in Examples 1-4.

As a result, as shown in FIG. 1 and FIG. 2, it was confirmed that both TUKEY HSD and LSD showed significant results in wake and rem in the group (A400) in which the herbal extract was administered at a concentration of 400 mg / kg. Also, there was a tendency of wake reduction / rem increase with increasing drug concentration.

2-2. Identification of effect of sleep enhancement on Aß42 transgenic Drosophila dementia model by combination herbal medicine extract

In order to confirm the effects of the herbal extracts of the present invention on the locomotor activity of the fruit flies, the herbal extracts prepared in Example 1-1 were mixed at a weight ratio of 1: 1: 1; (Drosophila Activity Monitoring System, DAM; Tri- kinetics, Waltham, MA, USA) was added to a 5% sucrose and 1% agar medium at a concentration of 100 mg / Was used to evaluate the level of locomotor activity.

More specifically, the DAM system was performed in a dark environment for 4 days (3 days of normal diet, 4 days of treatment with an amino acid in a sucrose agar medium), and the experimental group was a control group, a complex herbal extract treatment group (HED), acid treatment group, and luciferase treatment group. The animals were adapted for 24 hours in a tube of 10 animals per group, and the activity was recorded for 4 days at 1 minute intervals and the average activity for 4 days was calculated.

The results were expressed as mean ± standard deviation (SEM), and significance level was defined as p <0.05 vs. elav> Aß42 and #p <0.05 vs elav> Aß42 +

As a result, as shown in FIG. 3, it was confirmed that the night mobility of the herbal extract-treated group (HED) was significantly lower than that of the control group, and the low mobility was significantly increased compared with the control group.

It will be understood by those skilled in the art that the foregoing description of the present invention is for illustrative purposes only and that those of ordinary skill in the art can readily understand that various changes and modifications may be made without departing from the spirit or essential characteristics of the present invention. will be. It is therefore to be understood that the above-described embodiments are illustrative in all aspects and not restrictive.

Claims (11)

A composition for enhancing or improving sleep quality, comprising an extract of a complex herbal medicine of Lilium, Liliaceae, and Yongcheng as an active ingredient.
A pharmaceutical composition for the prevention or treatment of sleep disorders or insomnia, which comprises as an active ingredient, a herbal medicine extract of a combination of lupine, lupine, and lupine.
The pharmaceutical composition according to claim 2, wherein the extract is extracted using water, a C ₁ to C ₄ lower alcohol, or a mixed solvent thereof.
The pharmaceutical composition according to claim 3, wherein the lower alcohol is ethanol.
[Claim 3] The pharmaceutical composition according to claim 2, wherein the extract is a mixture of scutellaria baicalensis, horsetail, and canola oil mixed in a weight ratio of 1: 0.1 to 10: 0.1 to 10.
6. The pharmaceutical composition according to claim 5, wherein the weight ratio is 1: 1: 1.
A composition for health functional food for improving sleeping disorder or insomnia, which comprises as an active ingredient, a herbal medicine extract of a combination of lupus erythematosus, lupus erythematosus, and lupus erythematosus.
The health functional food composition according to claim 7, wherein the extract is extracted with water, a C ₁ to C ₄ lower alcohol, or a mixed solvent thereof.
The health functional food composition according to claim 8, wherein the lower alcohol is ethanol.
[Claim 7] The health functional food composition according to claim 7, wherein the extract is prepared by mixing the fish extracts, the herbal extracts, and the yogurts at a weight ratio of 1: 0.1 to 10: 0.1 to 10.
The health functional food composition according to claim 10, wherein the weight ratio is 1: 1: 1.

Images